Secura Bio has acquired 2 companies, including 1 in the last 5 years.
Secura Bio’s largest acquisition to date was in 2020, when it acquired Verastem - COPIKTRA for $381M. Secura Bio has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).
200 Connell Dr, Suite 1100,
Berkeley Heights, New Jersey
07922
United States,
www.securabio.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2020-09-30 |
Verastem, Inc. - COPIKTRA (duvelisib) · Life Science
Needham, Massachusetts Verastem's COPIKTRA (duvelisib) is an oral inhibitor of phosphoinositide 3-kinase (PI3K), and the first FDA-approved dual inhibitor of PI3K-delta and PI3K-gamma. |
381 | Divestiture |
Verastem
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
